Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

April 30, 2007

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL

Pneumococcal Conjugated Vaccine (Prevnar®)

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00488371 - Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar® | Biotech Hunter | Biotech Hunter